Financial statements Art-Pharma

Balance sheet of Art-Pharma

Company age:
Age:
23 y. 6 m. 14 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of ART-PHARMA

Year
2018
2019
2020
2021
2022
2023
Total assets 2 668 363,67 2 478 245,45 3 194 651,10 3 113 122,10 3 346 950,33 3 555 605,85
A. Fixed assets 544 534,45 594 630,48 742 148,57 794 986,52 993 674,92 907 082,12
B. Current assets 2 123 829,22 1 883 614,97 2 452 502,53 2 318 135,58 2 353 275,41 2 648 523,73
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 2 668 363,67 2 478 245,45 3 194 651,10 3 113 122,10 3 346 950,33 3 555 605,85
A. Equity 660 471,44 985 789,59 1 333 983,41 2 058 581,72 1 435 124,39 1 853 219,14
B. Liabilities and provisions for liabilities 2 007 892,23 1 492 455,86 1 860 667,69 1 054 540,38 1 911 825,94 1 702 386,71
I. Long-term liabilities 558 252,48 246 752,48 10 000,00 10 000,00 10 000,00 0,00
II. Short-term liabilities 1 449 639,75 1 245 703,38 1 850 667,69 1 044 540,38 1 901 825,94 1 702 386,71
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.